Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

被引:30
|
作者
Aguilar, Eduardo [2 ]
Maria Garcia-Diaz, Ana [3 ]
Sanchez Munoz-Torrero, Juan Francisco [4 ]
Ramon Alvarez, Lorenzo [5 ]
Piedecausa, Mar [6 ]
Arnedo, Gemma [7 ]
Monreal, Manuel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Dept Internal Med, Badalona 08916, Barcelona, Spain
[2] Hosp Alcaniz, Dept Internal Med, Alcaniz, Teruel, Spain
[3] ABS Gaudi, Primary Healthcare, Barcelona, Spain
[4] Hosp San Pedro de Alcantara, Dept Internal Med, Caceres, Spain
[5] Hosp Terrassa, Dept Vasc Surg, Barcelona, Spain
[6] Hosp Gen Univ Elche, Dept Internal Med, Alicante, Spain
[7] Hosp Badalona Germans Trias & Pujol, Dept Vasc Surg, Badalona 08916, Barcelona, Spain
关键词
Atrial fibrillation; Ayocardial infarction; Atroke; Bleeding; Antiplatelets; Anticoagulants; ANTITHROMBOTIC THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; PREVENT STROKE; TASK-FORCE; RISK; ASPIRIN; CLOPIDOGREL; MANAGEMENT; WARFARIN;
D O I
10.1016/j.thromres.2012.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The influence of atrial fibrillation (AF) on outcome in patients with symptomatic atherosclerotic disease has not been thoroughly studied. Methods: FRENA is an ongoing registry of stable outpatients with coronary (CAD), cerebrovascular (CVD), or peripheral (PAD) artery disease. With the aim to guide therapy, we assessed the incidence of subsequent myocardial infarction (MI), ischemic stroke or major bleeding in patients with AF, according to initial presentation. Results: As of June 2011, 3848 patients were recruited: 1436 had CAD, 1104 CVD, and 1308 had PAD. Of these, 470 (12%) had AF: 151 patients with CAD, 157 with CVD, and 162 with PAD. Over a mean follow-up of 16 +/- 13 months, 19 patients with AF developed acute MI, 22 ischemic stroke and 7 bled. Among AF patients with CAD, the incidence of subsequent MI (5.00 events per 100 patient-years; 95% CI: 2.54-8.91) was non-significantly higher than that of stroke (1.48; 95% CI: 0.38-4.04) or major bleeding (1.47; 95% CI: 0.37-4.01). Among those with CVD, the incidence of stroke (5.61; 95% CI: 2.95-9.75) exceeded that of MI (no events) or major bleeding (0.51; 95% CI: 1.24-6.36). Among those with PAD, the incidence of MI (4.41; 95% CI: 2.15-8.10) and stroke (3.93; 95% CI: 1.82-7.46) were similar. Conclusions: CAD patients with AF are at a higher risk of subsequent MI than of stroke. Among those with CVD, the risk of stroke far exceeds that of MI. Those with PAD have a high and similar risk for both events. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [21] Antithrombotic therapy in acute coronary syndrome and stable coronary artery disease patients with atrial fibrillation: a 3-year retrospective cohort study
    Wu, Jun
    Lin, Shenglan
    Men, Chen
    Wang, Xiangming
    Wang, Sen
    Hong, Jian
    Xu, Di
    Guo, Yan
    PERSONALIZED MEDICINE, 2019, 16 (05) : 399 - 407
  • [22] Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease
    Rohla, Miklos
    Vennekate, Christoph Kleine
    Tentzeris, Ioannis
    Freynhofer, Matthias K.
    Farhan, Serdar
    Egger, Florian
    Weiss, Thomas W.
    Wojta, Johann
    Granger, Christopher B.
    Huber, Kurt
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 108 - 114
  • [23] Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
    Wei, Lili
    Su, Enyong
    Liu, Weili
    Xing, Wenlu
    Liu, Xinyun
    Zhang, You
    Wang, Shan
    Cheng, Qianqian
    Qi, Datun
    Gao, Chuanyu
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [24] Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
    Cho, Min Soo
    Kang, Do-Yoon
    Ahn, Jung-Min
    Yun, Sung-Cheol
    Oh, Yong-Seog
    Lee, Chang Hoon
    Choi, Eue-Keun
    Lee, Ji Hyun
    Kwon, Chang Hee
    Park, Gyung-Min
    Choi, Hyung Oh
    Park, Kyoung-Ha
    Park, Kyoung-Min
    Hwang, Jongmin
    Yoo, Ki-Dong
    Cho, Young-Rak
    Kim, Ji Hyun
    Hwang, Ki Won
    Jin, Eun-Sun
    Kwon, Osung
    Kim, Ki-Hun
    Park, Seung-Jung
    Park, Duk-Woo
    Nam, Gi-Byoung
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (22): : 2075 - 2086
  • [25] Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
    Fauchier, Laurent
    Greenlaw, Nicola
    Ferrari, Roberto
    Ford, Ian
    Fox, Kim M.
    Tardif, Jean-Claude
    Tendera, Michal
    Steg, Ph. Gabriel
    PLOS ONE, 2015, 10 (04):
  • [26] Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
    Lee, Kuo-Hua
    Ou, Shuo-Ming
    Chu, Yuan-Chia
    Lin, Yao-Ping
    Tsai, Ming-Tsun
    Tarng, Der-Cherng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [27] Effect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation
    Schurtz, Guillaume
    Bauters, Christophe
    Ducrocq, Gregory
    Lamblin, Nicolas
    Lemesle, Gilles
    PANMINERVA MEDICA, 2016, 58 (04) : 271 - 285
  • [29] Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
    Chan, Pak Hei
    Li, Wen Hua
    Hai, Jo Jo
    Tse, Hung Fat
    Siu, Chung Wah
    PLOS ONE, 2015, 10 (06):
  • [30] Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease
    Lopes, Renato D.
    Thomas, Laine
    Di Fusco, Manuela
    Keshishian, Allison
    Luo, Xuemei
    Li, Xiaoyan
    Masseria, Cristina
    Friend, Keith
    Mardekian, Jack
    Pan, Xianying
    Yuce, Huseyin
    Jones, W. Schuyler
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 148 : 69 - 77